The American Medical Association is calling on insurance companies and federal payers alike to cover the cost of a new class obesity treatments, such as Wegovy and Ozempic. This is despite plans looking for ways to avoid the high price of these drugs. The organization voted on Monday to support “health insurance parity for evidence-based treatments of…
Yet as plans look for ways to avoid paying for the high cost of the medications, the American Medical Association wants insurance companies and governmental payers to completely cover a new class of obesity treatments like Wegovy and Ozempic. The group voted on Monday to pass a resolution promoting “health insurance coverage parity for evidence-based treatmentof…” Yet as plans look for ways to avoid paying for the high cost of the medications, the American Medical Association wants insurance companies and federal payers to completely cover a new class of obesity treatments like Wegovy and Ozempic. A resolution supporting “health insurance coverage parity for evidence-based treatmentof…” was approved by the organization on Monday.
The American Medical Association is calling on insurance companies and federal payers alike to cover the cost of a new class obesity treatments, such as Wegovy and Ozempic. This is despite plans looking for ways to avoid the high price of these drugs. The organization voted on Monday to support “health insurance parity for evidence-based treatments of…
